Literature DB >> 10749164

Mucoepidermoid carcinoma of an accessory lacrimal gland with orbital invasion.

S Dithmar1, T H Wojno, C Washington, H E Grossniklaus.   

Abstract

PURPOSE: To report a case of mucoepidermoid carcinoma of an accessory lacrimal gland with orbital invasion.
METHODS: The clinical history and pathologic findings of a patient with a left upper eyelid lesion were reviewed.
RESULTS: The patient was evaluated and found to have an epithelial tumor arising in an accessory lacrimal gland. Special stains showed mucin production by individual tumor cells. The tumor was classified as mucoepidermoid carcinoma.
CONCLUSIONS: Mucoepidermoid carcinoma may arise in accessory lacrimal glands and invade the orbit.

Entities:  

Mesh:

Year:  2000        PMID: 10749164     DOI: 10.1097/00002341-200003000-00012

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  Adenocarcinoma, Not Otherwise Specified, Arising in Accessory Lacrimal Gland: A Diagnostic Challenge.

Authors:  Tatyana Milman; Codrin Iacob; Simeon Lauer; Michael D Feldman; Paul J L Zhang
Journal:  Ocul Oncol Pathol       Date:  2017-08-12

2.  [Adenoid cystic carcinoma of the upper eyelid].

Authors:  J C Paarlberg; J C den Hollander; F Hafezi; D Paridaens
Journal:  Ophthalmologe       Date:  2007-12       Impact factor: 1.059

3.  Mucoepidermoid Carcinoma of the Breast Found during Treatment of Lymphoma.

Authors:  Minoru Fujino; Daisuke Mori; Michiaki Akashi; Hidetaka Yamamoto; Hitoshi Aibe; Kunishige Matake; Kengo Shirahane
Journal:  Case Rep Oncol       Date:  2016-11-29

4.  Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient.

Authors:  Ozgun Melike Gedar Totuk; Mustafa Kemal Demir; Ozlem Yapicier; Mert Mestanoglu
Journal:  Case Rep Ophthalmol Med       Date:  2017-11-28

5.  Secondary mucoepidermoid carcinoma of the orbit.

Authors:  Chin Pei Siuw; Siow W Tan; Adrena B Abdul Wahid; Suresh Vasudevan
Journal:  Indian J Ophthalmol       Date:  2016-03       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.